Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook
twitter
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
Medicine Availability
Support

Home > Safety Info > Safety Communication > Safety Alerts > Safety Alert of Risk of Drug-Induced Liver Injury (DILI) and Severe Cutaneous
Adverse Reactions (SCARs) with Ezetimibe

Safety Alert of Risk of Drug-Induced Liver Injury (DILI) and Severe Cutaneous
Adverse Reactions (SCARs) with Ezetimibe

Abdul Qadir Safety Alerts April 7, 2025April 7, 2025

Safety-Alert-of-Risk-of-Drug-Induced-Liver-Injury-DILI-and-Severe-Cutaneous Download

Share this:

Twitter
Facebook

← Safety Alert of Risk of pathological gambling with Aripiprazole
Safety Alert risk of severe chemical irritation and damage to tissues with
Promethazine hydrochloride injection →

Product Recalls
Safety Communication
Safety Reporting

Quick Navigation

Quick Navigation

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem